Artelo biosciences to present at the h.c. wainwright global investment conference on may 24th

Solana beach, calif., may 16, 2022 (globe newswire) -- artelo biosciences, inc. “artelo” or the “company”) (nasdaq: artl), a clinical stage pharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the endocannabinoid system, today announced that gregory d. gorgas, chief executive officer of artelo, will be presenting at the h.c. wainwright global investment conference which is being held on may 23- may 26, 2022 at the fontainebleau miami beach hotel, miami fl. the conference will include virtual and in-person participation.
ARTL Ratings Summary
ARTL Quant Ranking